메뉴 건너뛰기




Volumn 40, Issue 12, 2017, Pages 1631-1640

International consensus on use of continuous glucose monitoring

(34)  Danne, Thomas a   Nimri, Revital b   Battelino, Tadej c   Bergenstal, Richard M d   Close, Kelly L e   DeVries, J Hans f   Garg, Satish g   Heinemann, Lutz h   Hirsch, Irl i   Amiel, Stephanie A j   Beck, Roy k   Bosi, Emanuele l   Buckingham, Bruce m   Cobelli, Claudio n   Dassau, Eyal o   Doyle, Francis J o   Heller, Simon p   Hovorka, Roman q   Jia, Weiping r   Jones, Tim s   more..


Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; INSULIN;

EID: 85036620716     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc17-1600     Document Type: Article
Times cited : (1456)

References (83)
  • 1
    • 84884200796 scopus 로고    scopus 로고
    • Structured self-monitoring of blood glucose reduces glycated hemoglobin in insulin-treated diabetes
    • Kato N, Cui J, Kato M. Structured self-monitoring of blood glucose reduces glycated hemoglobin in insulin-treated diabetes. J Diabetes Investig 2013; 4:450-453
    • (2013) J Diabetes Investig , vol.4 , pp. 450-453
    • Kato, N.1    Cui, J.2    Kato, M.3
  • 2
    • 79951717523 scopus 로고    scopus 로고
    • Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: Results from the Structured Testing Program study
    • Polonsky WH, Fisher L, Schikman CH, et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Diabetes Care 2011;34:262-26
    • (2011) Diabetes Care , vol.34 , pp. 262-326
    • Polonsky, W.H.1    Fisher, L.2    Schikman, C.H.3
  • 3
    • 79958816342 scopus 로고    scopus 로고
    • ROSES study group. ROSES: Role of self-monitoring of blood glucose and intensive education in patients with type 2 diabetes not receiving insulin. A pilot randomized clinical trial
    • Franciosi M, Lucisano G, Pellegrini F, et al.; ROSES Study Group. ROSES: role of self-monitoring of blood glucose and intensive education in patients with type 2 diabetes not receiving insulin. A pilot randomized clinical trial. Diabet Med 2011;28:789-796
    • (2011) Diabet Med , vol.28 , pp. 789-796
    • Franciosi, M.1    Lucisano, G.2    Pellegrini, F.3
  • 4
    • 84855419162 scopus 로고    scopus 로고
    • ROSSO-in-praxi follow-up: Long-term effects of self-monitoring of blood glucose on weight, hemoglobin A1c, and quality of life in patients with type 2 diabetes mellitus
    • Kempf K, Kruse J, Martin S. ROSSO-in-praxi follow-up: long-term effects of self-monitoring of blood glucose on weight, hemoglobin A1c, and quality of life in patients with type 2 diabetes mellitus. Diabetes Technol Ther 2012;14:59-64
    • (2012) Diabetes Technol Ther , vol.14 , pp. 59-64
    • Kempf, K.1    Kruse, J.2    Martin, S.3
  • 5
    • 0030763585 scopus 로고    scopus 로고
    • Hypoglycaemia unawareness
    • Bolli GB. Hypoglycaemia unawareness. Diabetes Metab 1997;23(Suppl. 3):29-35
    • (1997) Diabetes Metab , vol.23 , pp. 29-35
    • Bolli, G.B.1
  • 6
    • 0028292096 scopus 로고
    • Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia
    • Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care 1994;17:697-703
    • (1994) Diabetes Care , vol.17 , pp. 697-703
    • Gold, A.E.1    MacLeod, K.M.2    Frier, B.M.3
  • 7
    • 33750469241 scopus 로고    scopus 로고
    • Standards of medical care in diabetesd 2017
    • American Diabetes Association. Standards of Medical Care in Diabetesd 2017. Diabetes Care 2017;40(Suppl. 1):S1-S135
    • (2017) Diabetes Care , vol.40 , pp. S1-S135
  • 8
    • 84920538565 scopus 로고    scopus 로고
    • Writing group for the DCCT/EDIC Research Group. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality
    • Orchard TJ, Nathan DM, Zinman B, et al.; Writing Group for the DCCT/EDIC Research Group. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. JAMA 2015;313:45-53
    • (2015) JAMA , vol.313 , pp. 45-53
    • Orchard, T.J.1    Nathan, D.M.2    Zinman, B.3
  • 10
    • 84982074515 scopus 로고    scopus 로고
    • American association of clinical endocrinologists (AACE); American College of endocrinology (ACE). Consensus statement by the American association of clinical endocrinologists and American college of endocrinology on the comprehensive type 2 diabetesmanagement algorithm- 2016 Executive Summary
    • Garber AJ, Abrahamson MJ, Barzilay JI, et al.; American Association of Clinical Endocrinologists (AACE); American College of Endocrinology (ACE). Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetesmanagement algorithm- 2016 Executive Summary. Endocr Pract 2016;22:84-113
    • (2016) Endocr Pract , vol.22 , pp. 84-113
    • Garber, A.J.1    Abrahamson, M.J.2    Barzilay, J.I.3
  • 11
    • 85036611399 scopus 로고    scopus 로고
    • National Institute for Health and Care Excellence (NICE). NICE guideline [NG18]. London, U.K., National Institute for Health and Care Excellence. Accessed 4 May
    • National Institute for Health and Care Excellence (NICE). Diabetes (type 1 and type 2) in children and young people: diagnosis and management, 2015. NICE guideline [NG18]. London, U.K., National Institute for Health and Care Excellence. Available fromwww.nice.org.uk/guidance/NG18. Accessed 4 May 2017
    • (2017) Diabetes (Type 1 and Type 2) in Children and Young People: Diagnosis and Management, 2015
  • 12
    • 85036623981 scopus 로고    scopus 로고
    • National Institute of Diabetes and Digestive and Kidney Diseases. Accessed 26 August 2017
    • National Institute of Diabetes and Digestive and Kidney Diseases. Sickle cell trait & other hemoglobinopathies & diabetes (for providers) [Internet], 2014. Available from http://diabetes.niddk.nih.gov/dm/pubs/hemovari-A1C/index.aspx. Accessed 26 August 2017
    • (2014) Sickle Cell Trait & Other Hemoglobinopathies & Diabetes (For Providers) [Internet]
  • 13
    • 0035134867 scopus 로고    scopus 로고
    • Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin
    • Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem 2001; 47:153-163
    • (2001) Clin Chem , vol.47 , pp. 153-163
    • Bry, L.1    Chen, P.C.2    Sacks, D.B.3
  • 14
    • 79951790757 scopus 로고    scopus 로고
    • Iron-deficiency anemia, noniron-deficiency anemia and HbA1c among adults in the US
    • Ford ES, Cowie CC, Li C, Handelsman Y, Bloomgarden ZT. Iron-deficiency anemia, noniron-deficiency anemia and HbA1c among adults in the US. J Diabetes 2011;3:67-73
    • (2011) J Diabetes , vol.3 , pp. 67-73
    • Ford, E.S.1    Cowie, C.C.2    Li, C.3    Handelsman, Y.4    Bloomgarden, Z.T.5
  • 15
    • 2342626736 scopus 로고    scopus 로고
    • 1c levels are significantly lower in early and late pregnancy
    • 1c levels are significantly lower in early and late pregnancy. Diabetes Care 2004;27:1200-1201
    • (2004) Diabetes Care , vol.27 , pp. 1200-1201
    • Nielsen, L.R.1    Ekbom, P.2    Damm, P.3
  • 16
    • 85025067894 scopus 로고    scopus 로고
    • T1D exchange racial differences study group. Racial differences in the relationship of glucose concentrations and hemoglobin A1c levels
    • Bergenstal RM, Gal RL, Connor CG, et al.; T1D Exchange Racial Differences Study Group. Racial differences in the relationship of glucose concentrations and hemoglobin A1c levels. Ann Intern Med 2017;167:95-102
    • (2017) Ann Intern Med , vol.167 , pp. 95-102
    • Bergenstal, R.M.1    Gal, R.L.2    Connor, C.G.3
  • 20
    • 85028041245 scopus 로고    scopus 로고
    • The fallacy of average: How using HbA1c alone to assess glycemic control can be misleading
    • Beck RW, Connor CG, Mullen DM, Wesley, DM, Bergenstal RM. The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading. Diabetes Care 2017;40:994-999
    • (2017) Diabetes Care , vol.40 , pp. 994-999
    • Beck, R.W.1    Connor, C.G.2    Mullen, D.M.3    Wesley, D.M.4    Bergenstal, R.M.5
  • 22
    • 0027370108 scopus 로고
    • Diabetes control and complications trial research group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
    • Nathan DM, Genuth S, Lachin J, et al.; Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986
    • (1993) N Engl J Med , vol.329 , pp. 977-986
    • Nathan, D.M.1    Genuth, S.2    Lachin, J.3
  • 24
    • 84994553148 scopus 로고    scopus 로고
    • Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: A multicentre, non-masked, randomised controlled trial
    • Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kröger J, Weitgasser R. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet 2016;388:2254-2263
    • (2016) Lancet , vol.388 , pp. 2254-2263
    • Bolinder, J.1    Antuna, R.2    Geelhoed-Duijvestijn, P.3    Kröger, J.4    Weitgasser, R.5
  • 25
    • 85012186707 scopus 로고    scopus 로고
    • Flash glucose-sensing technology as a replacement for blood glucose monitoring for themanagement of insulin-treated type 2 diabetes: A multicenter, open-label randomized controlled trial
    • Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for themanagement of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther 2016;8:55-73
    • (2016) Diabetes Ther , vol.8 , pp. 55-73
    • Haak, T.1    Hanaire, H.2    Ajjan, R.3    Hermanns, N.4    Riveline, J.P.5    Rayman, G.6
  • 26
    • 85008234027 scopus 로고    scopus 로고
    • Accuracy and longevity of an implantable continuous glucose sensor in the PRECISE study: A 180-day, prospective, multicenter, pivotal trial
    • Kropff J, Choudhary P, Neupane S, et al. Accuracy and longevity of an implantable continuous glucose sensor in the PRECISE study: a 180-day, prospective, multicenter, pivotal trial. Diabetes Care 2017;40:63-68
    • (2017) Diabetes Care , vol.40 , pp. 63-68
    • Kropff, J.1    Choudhary, P.2    Neupane, S.3
  • 27
    • 74249090188 scopus 로고    scopus 로고
    • Effectiveness of continuous glucose monitoring in a clinical care environment: Evidence from the juvenile diabetes research foundation continuous glucose monitoring (JDRF-CGM) trial
    • Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring (JDRF-CGM) trial. Diabetes Care 2010; 33:17-22
    • (2010) Diabetes Care , vol.33 , pp. 17-22
  • 28
    • 79960098673 scopus 로고    scopus 로고
    • 1c in suboptimally controlled type 1 diabetes; A randomized controlled trial
    • 1c in suboptimally controlled type 1 diabetes; a randomized controlled trial. Diabet Med 2011; 28:1158-1167
    • (2011) Diabet Med , vol.28 , pp. 1158-1167
    • Hermanides, J.1    Nørgaard, K.2    Bruttomesso, D.3
  • 29
    • 84868213630 scopus 로고    scopus 로고
    • SWITCH study group. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: A randomised controlled trial
    • Battelino T, Conget I, Olsen B, et al.; SWITCH Study Group. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia 2012;55:3155-3162
    • (2012) Diabetologia , vol.55 , pp. 3155-3162
    • Battelino, T.1    Conget, I.2    Olsen, B.3
  • 30
    • 84928048519 scopus 로고    scopus 로고
    • Continuous glucose monitoring in people with diabetes: The randomized controlled Glucose level awareness in diabetes study (GLADIS)
    • New JP, Ajjan R, Pfeiffer AF, Freckmann G. Continuous glucose monitoring in people with diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study (GLADIS). Diabet Med 2015;32:609-617
    • (2015) Diabet Med , vol.32 , pp. 609-617
    • New, J.P.1    Ajjan, R.2    Pfeiffer, A.F.3    Freckmann, G.4
  • 31
    • 84908164031 scopus 로고    scopus 로고
    • T1D exchange clinic network. Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry
    • Wong JC, Foster NC, Maahs DM, et al.; T1D Exchange Clinic Network. Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. Diabetes Care 2014;37:2702-2709
    • (2014) Diabetes Care , vol.37 , pp. 2702-2709
    • Wong, J.C.1    Foster, N.C.2    Maahs, D.M.3
  • 32
    • 84862113120 scopus 로고    scopus 로고
    • EVADIAC sensor study group. Assessment of patient-led or physician-driven continuous glucose monitoring in patientswith poorly controlled type 1 diabetes using basal-bolus insulin regimens: A 1-year multicenter study
    • Riveline JP, Schaepelynck P, Chaillous L, et al.; EVADIAC Sensor Study Group. Assessment of patient-led or physician-driven continuous glucose monitoring in patientswith poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year multicenter study. Diabetes Care 2012;35:965-971
    • (2012) Diabetes Care , vol.35 , pp. 965-971
    • Riveline, J.P.1    Schaepelynck, P.2    Chaillous, L.3
  • 33
    • 84925588374 scopus 로고    scopus 로고
    • The use of continuous glucose monitoring systems in a pediatric population with type 1 diabetes mellitus in real-life settings: The A We SoMe Study Group experience
    • Rachmiel M, Landau Z, Boaz M, et al. The use of continuous glucose monitoring systems in a pediatric population with type 1 diabetes mellitus in real-life settings: the A We SoMe Study Group experience. Acta Diabetol 2015;52:323-329
    • (2015) Acta Diabetol , vol.52 , pp. 323-329
    • Rachmiel, M.1    Landau, Z.2    Boaz, M.3
  • 34
    • 84880274350 scopus 로고    scopus 로고
    • ASPIRE in-home study group. Threshold-based insulin-pump interruption for reduction of hypoglycemia
    • Bergenstal RM, Klonoff DC, Garg SK, et al.; ASPIRE In-Home Study Group. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 2013;369:224-232
    • (2013) N Engl J Med , vol.369 , pp. 224-232
    • Bergenstal, R.M.1    Klonoff, D.C.2    Garg, S.K.3
  • 35
    • 84881505727 scopus 로고    scopus 로고
    • T1D exchange clinic network. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: Results from the T1D Exchange clinic registry
    • Weinstock RS, Xing D, Maahs DM, et al.; T1D Exchange Clinic Network. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. J Clin Endocrinol Metab 2013;98:3411-3419
    • (2013) J Clin Endocrinol Metab , vol.98 , pp. 3411-3419
    • Weinstock, R.S.1    Xing, D.2    Maahs, D.M.3
  • 36
    • 79960319709 scopus 로고    scopus 로고
    • Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: Meta-analysis of randomised controlled trials using individual patient data
    • Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ 2011;343:d3805
    • (2011) BMJ , vol.343 , pp. d3805
    • Pickup, J.C.1    Freeman, S.C.2    Sutton, A.J.3
  • 37
    • 79956157918 scopus 로고    scopus 로고
    • Use of continuous glucose monitoring in subjectswith type 1 diabetes onmultiple daily injections versus continuous subcutaneous insulin infusion therapy: A prospective 6-month study
    • Garg SK, Voelmle MK, Beatson CR, et al. Use of continuous glucose monitoring in subjectswith type 1 diabetes onmultiple daily injections versus continuous subcutaneous insulin infusion therapy: a prospective 6-month study. Diabetes Care 2011;34:574-579
    • (2011) Diabetes Care , vol.34 , pp. 574-579
    • Garg, S.K.1    Voelmle, M.K.2    Beatson, C.R.3
  • 38
    • 85011898350 scopus 로고    scopus 로고
    • DIAMOND study group. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: The DIAMOND randomized clinical trial
    • Beck RW, Riddlesworth T, Ruedy K, et al.; DIAMOND Study Group. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA 2017; 317:371-378
    • (2017) JAMA , vol.317 , pp. 371-378
    • Beck, R.W.1    Riddlesworth, T.2    Ruedy, K.3
  • 39
    • 77954833147 scopus 로고    scopus 로고
    • Juvenile diabetes research foundation continuous glucose monitoring study group. The cost-effectiveness of continuous glucose monitoring in type 1 diabetes
    • Huang ES, O'Grady M, Basu A, et al.; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The cost-effectiveness of continuous glucose monitoring in type 1 diabetes. Diabetes Care 2010;33:1269-1274
    • (2010) Diabetes Care , vol.33 , pp. 1269-1274
    • Huang, E.S.1    O'Grady, M.2    Basu, A.3
  • 40
    • 80052828858 scopus 로고    scopus 로고
    • Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes
    • McQueen RB, Ellis SL, Campbell JD, Nair KV, Sullivan PW. Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes. Cost Eff Resour Alloc 2011;9:13
    • (2011) Cost Eff Resour Alloc , vol.9 , pp. 13
    • McQueen, R.B.1    Ellis, S.L.2    Campbell, J.D.3    Nair, K.V.4    Sullivan, P.W.5
  • 41
    • 84928048461 scopus 로고    scopus 로고
    • Health-economic analysis of real-time continuous glucose monitoring in people with type 1 diabetes
    • Roze S, Saunders R, Brandt AS, de Portu S, Papo NL, Jendle J. Health-economic analysis of real-time continuous glucose monitoring in people with type 1 diabetes. Diabet Med 2015;32: 618-626
    • (2015) Diabet Med , vol.32 , pp. 618-626
    • Roze, S.1    Saunders, R.2    Brandt, A.S.3    De Portu, S.4    Papo, N.L.5    Jendle, J.6
  • 42
    • 84906260788 scopus 로고    scopus 로고
    • A costeffectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes
    • Ly TT, Brnabic AJ, Eggleston A, et al. A costeffectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes. Value Health 2014;17:561-569
    • (2014) Value Health , vol.17 , pp. 561-569
    • Ly, T.T.1    Brnabic, A.J.2    Eggleston, A.3
  • 43
    • 84959096594 scopus 로고    scopus 로고
    • Long-term health economic benefits of sensoraugmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: A U.K. Perspective
    • Roze S, Smith-Palmer J, Valentine WJ, et al. Long-term health economic benefits of sensoraugmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective. J Med Econ 2016;19:236-242
    • (2016) J Med Econ , vol.19 , pp. 236-242
    • Roze, S.1    Smith-Palmer, J.2    Valentine, W.J.3
  • 44
    • 84957589959 scopus 로고    scopus 로고
    • Cost-effectiveness of sensor-augmented pump therapy with low glucose suspend versus standard insulin pump therapy in two different patient populations with type 1 diabetes in France
    • Roze S, Smith-Palmer J, Valentine W, et al. Cost-effectiveness of sensor-augmented pump therapy with low glucose suspend versus standard insulin pump therapy in two different patient populations with type 1 diabetes in France. Diabetes Technol Ther 2016;18:75-84
    • (2016) Diabetes Technol Ther , vol.18 , pp. 75-84
    • Roze, S.1    Smith-Palmer, J.2    Valentine, W.3
  • 45
    • 85029688306 scopus 로고    scopus 로고
    • DIAMOND study group. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: A randomized trial
    • Beck RW, Riddlesworth TD, Ruedy K, et al.; DIAMOND Study Group. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med 2017;167:365-374
    • (2017) Ann Intern Med , vol.167 , pp. 365-374
    • Beck, R.W.1    Riddlesworth, T.D.2    Ruedy, K.3
  • 46
    • 52949108795 scopus 로고    scopus 로고
    • Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes
    • Yoo HJ, An HG, Park SY, et al. Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes. Diabetes Res Clin Pract 2008;82: 73-79
    • (2008) Diabetes Res Clin Pract , vol.82 , pp. 73-79
    • Yoo, H.J.1    An, H.G.2    Park, S.Y.3
  • 47
    • 84859038969 scopus 로고    scopus 로고
    • Short-and long-termeffects of real-time continuous glucose monitoring in patients with type 2 diabetes
    • Vigersky RA, Fonda SJ, Chellappa M, Walker MS, Ehrhardt NM. Short-and long-termeffects of real-time continuous glucose monitoring in patients with type 2 diabetes. Diabetes Care 2012; 35:32-38
    • (2012) Diabetes Care , vol.35 , pp. 32-38
    • Vigersky, R.A.1    Fonda, S.J.2    Chellappa, M.3    Walker, M.S.4    Ehrhardt, N.M.5
  • 48
    • 85019701140 scopus 로고    scopus 로고
    • Clinical use of continuous glucose monitoring in adults with type 2 diabetes
    • Carlson AL, Mullen DM, Bergenstal RM. Clinical use of continuous glucose monitoring in adults with type 2 diabetes. Diabetes Technol Ther 2017;19(Suppl. 2):S4-S11
    • (2017) Diabetes Technol Ther , vol.19 , pp. S4-S11
    • Carlson, A.L.1    Mullen, D.M.2    Bergenstal, R.M.3
  • 49
    • 84890178263 scopus 로고    scopus 로고
    • Performance evaluations of continuous glucose monitoring systems: Precision absolute relative deviation is part of the assessment
    • Obermaier K, Schmelzeisen-Redeker G, Schoemaker M, et al. Performance evaluations of continuous glucose monitoring systems: precision absolute relative deviation is part of the assessment. J Diabetes Sci Technol 2013;7:824-832
    • (2013) J Diabetes Sci Technol , vol.7 , pp. 824-832
    • Obermaier, K.1    Schmelzeisen-Redeker, G.2    Schoemaker, M.3
  • 50
    • 84923873485 scopus 로고    scopus 로고
    • Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring
    • Kovatchev BP, Patek SD, Ortiz EA, Breton MD. Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring. Diabetes Technol Ther 2015;17:177-186
    • (2015) Diabetes Technol Ther , vol.17 , pp. 177-186
    • Kovatchev, B.P.1    Patek, S.D.2    Ortiz, E.A.3    Breton, M.D.4
  • 51
    • 57249098943 scopus 로고    scopus 로고
    • The barrier of hypoglycemia in diabetes
    • Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes 2008;57:3169-3176
    • (2008) Diabetes , vol.57 , pp. 3169-3176
    • Cryer, P.E.1
  • 52
    • 84896403138 scopus 로고    scopus 로고
    • T1D exchange clinic network. A contrast between children and adolescents with excellent and poor control: The T1D Exchange clinic registry experience
    • Campbell MS, Schatz DA, Chen V, et al.; T1D Exchange Clinic Network. A contrast between children and adolescents with excellent and poor control: the T1D Exchange clinic registry experience. Pediatr Diabetes 2014;15:110-117
    • (2014) Pediatr Diabetes , vol.15 , pp. 110-117
    • Campbell, M.S.1    Schatz, D.A.2    Chen, V.3
  • 53
    • 84890876627 scopus 로고    scopus 로고
    • 1c and risk of severe hypoglycemia in type 2 diabetes: The Diabetes and Aging Study
    • 1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging Study. Diabetes Care 2013;36:3535-3542
    • (2013) Diabetes Care , vol.36 , pp. 3535-3542
    • Lipska, K.J.1    Warton, E.M.2    Huang, E.S.3
  • 54
    • 0026035949 scopus 로고
    • Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans
    • Heller SR, Cryer PE. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes 1991;40:223-226
    • (1991) Diabetes , vol.40 , pp. 223-226
    • Heller, S.R.1    Cryer, P.E.2
  • 55
    • 0026743146 scopus 로고
    • Further defects in counterregulatory responses induced by recurrent hypoglycemia in IDDM
    • Davis MR, Mellman M, Shamoon H. Further defects in counterregulatory responses induced by recurrent hypoglycemia in IDDM. Diabetes 1992;41:1335-1340
    • (1992) Diabetes , vol.41 , pp. 1335-1340
    • Davis, M.R.1    Mellman, M.2    Shamoon, H.3
  • 56
    • 0033761438 scopus 로고    scopus 로고
    • Effects of differing durations of antecedent hypoglycemia on counterregulatory responses to subsequent hypoglycemia in normal humans
    • Davis SN, Mann S, Galassetti P, et al. Effects of differing durations of antecedent hypoglycemia on counterregulatory responses to subsequent hypoglycemia in normal humans. Diabetes 2000; 49:1897-1903
    • (2000) Diabetes , vol.49 , pp. 1897-1903
    • Davis, S.N.1    Mann, S.2    Galassetti, P.3
  • 57
    • 70349086613 scopus 로고    scopus 로고
    • Human brain glycogen metabolismduring and after hypoglycemia
    • Öz G, Kumar A, Rao JP, et al. Human brain glycogen metabolismduring and after hypoglycemia. Diabetes 2009;58:1978-1985
    • (2009) Diabetes , vol.58 , pp. 1978-1985
    • Öz, G.1    Kumar, A.2    Rao, J.P.3
  • 59
    • 84962045891 scopus 로고    scopus 로고
    • Are risk indices derived from CGM interchangeable with SMBG-based indices?
    • Fabris C, Patek SD, Breton MD. Are risk indices derived from CGM interchangeable with SMBG-based indices? J Diabetes Sci Technol 2015;10:50-59
    • (2015) J Diabetes Sci Technol , vol.10 , pp. 50-59
    • Fabris, C.1    Patek, S.D.2    Breton, M.D.3
  • 61
    • 0035936519 scopus 로고    scopus 로고
    • Do interventions to reduce coronary heart disease reduce the incidence of type 2 diabetes? A possible role for inflammatory factors
    • Haffner SM. Do interventions to reduce coronary heart disease reduce the incidence of type 2 diabetes? A possible role for inflammatory factors. Circulation 2001;103:346-347
    • (2001) Circulation , vol.103 , pp. 346-347
    • Haffner, S.M.1
  • 62
    • 3142760075 scopus 로고    scopus 로고
    • Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus
    • Esposito K, Giugliano D, Nappo F, Marfella R; Campanian Postprandial Hyperglycemia Study Group. Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation 2004;110:214-219
    • (2004) Circulation , vol.110 , pp. 214-219
    • Esposito, K.1    Giugliano, D.2    Nappo, F.3    Marfella, R.4
  • 63
    • 33645745733 scopus 로고    scopus 로고
    • Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes
    • Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006;295: 1681-1687
    • (2006) JAMA , vol.295 , pp. 1681-1687
    • Monnier, L.1    Mas, E.2    Ginet, C.3
  • 64
    • 0028598563 scopus 로고
    • Frequency of severe hypoglycemia in insulin-dependent diabetesmellitus can be predicted fromself-monitoring blood glucose data
    • Cox DJ, Kovatchev BP, Julian DM, et al. Frequency of severe hypoglycemia in insulin-dependent diabetesmellitus can be predicted fromself-monitoring blood glucose data. J Clin Endocrinol Metab 1994;79:1659-1662
    • (1994) J Clin Endocrinol Metab , vol.79 , pp. 1659-1662
    • Cox, D.J.1    Kovatchev, B.P.2    Julian, D.M.3
  • 65
    • 84876528007 scopus 로고    scopus 로고
    • Glucose variability: Where it is important and how to measure it
    • DeVries JH. Glucose variability: where it is important and how to measure it. Diabetes 2013;62:1405-1408
    • (2013) Diabetes , vol.62 , pp. 1405-1408
    • DeVries, J.H.1
  • 66
    • 84962360946 scopus 로고    scopus 로고
    • Glycemic variability and diabetes complications: Does it matter?
    • Hirsch IB. Glycemic variability and diabetes complications: does it matter? Of course it does! Diabetes Care 2015;38:1610-1614
    • (2015) Of Course It Does! Diabetes Care , vol.38 , pp. 1610-1614
    • Hirsch, I.B.1
  • 67
    • 84876560326 scopus 로고    scopus 로고
    • Glucose variability
    • Service FJ. Glucose variability. Diabetes 2013; 62:1398-1404
    • (2013) Diabetes , vol.62 , pp. 1398-1404
    • Service, F.J.1
  • 69
    • 84877641520 scopus 로고    scopus 로고
    • Thechallenges ofmeasuringglycemic variability
    • Rodbard D. Thechallenges ofmeasuringglycemic variability. J Diabetes Sci Technol 2012;6:712-715
    • (2012) J Diabetes Sci Technol , vol.6 , pp. 712-715
    • Rodbard, D.1
  • 70
    • 84962110910 scopus 로고    scopus 로고
    • Glucose variability: Timing, risk analysis, and relationship to hypoglycemia in diabetes
    • Kovatchev B, Cobelli C. Glucose variability: timing, risk analysis, and relationship to hypoglycemia in diabetes. Diabetes Care 2016;39:502-510
    • (2016) Diabetes Care , vol.39 , pp. 502-510
    • Kovatchev, B.1    Cobelli, C.2
  • 71
    • 0027952951 scopus 로고
    • Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study
    • Reichard P, Pihl M. Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study. Diabetes 1994;43:313-317
    • (1994) Diabetes , vol.43 , pp. 313-317
    • Reichard, P.1    Pihl, M.2
  • 72
    • 84899046946 scopus 로고    scopus 로고
    • Accuracy and robustness of dynamical tracking of average glycemia (A1c) to provide real-time estimation of hemoglobin A1c using routine selfmonitored blood glucose data
    • Kovatchev BP, Flacke F, Sieber J, Breton MD. Accuracy and robustness of dynamical tracking of average glycemia (A1c) to provide real-time estimation of hemoglobin A1c using routine selfmonitored blood glucose data. Diabetes Technol Ther 2014;16:303-309
    • (2014) Diabetes Technol Ther , vol.16 , pp. 303-309
    • Kovatchev, B.P.1    Flacke, F.2    Sieber, J.3    Breton, M.D.4
  • 73
    • 33746621650 scopus 로고    scopus 로고
    • Variability of blood glucose concentration and short-term mortality in critically ill patients
    • Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006;105:244-252
    • (2006) Anesthesiology , vol.105 , pp. 244-252
    • Egi, M.1    Bellomo, R.2    Stachowski, E.3    French, C.J.4    Hart, G.5
  • 74
    • 79953834744 scopus 로고    scopus 로고
    • Glucose variability measures and their effect on mortality: A systematic review
    • Eslami S, Taherzadeh Z, Schultz MJ, Abu-Hanna A. Glucose variability measures and their effect on mortality: a systematic review. Intensive Care Med 2011;37:583-593
    • (2011) Intensive Care Med , vol.37 , pp. 583-593
    • Eslami, S.1    Taherzadeh, Z.2    Schultz, M.J.3    Abu-Hanna, A.4
  • 75
    • 84867089360 scopus 로고    scopus 로고
    • Rate of hypoglycemia in insulin-treated patients with type 2 diabetes can be predicted from glycemic variability data
    • Qu Y, Jacober SJ, Zhang Q, Wolka LL, DeVries JH. Rate of hypoglycemia in insulin-treated patients with type 2 diabetes can be predicted from glycemic variability data. Diabetes Technol Ther 2012;14:1008-1012
    • (2012) Diabetes Technol Ther , vol.14 , pp. 1008-1012
    • Qu, Y.1    Jacober, S.J.2    Zhang, Q.3    Wolka, L.L.4    DeVries, J.H.5
  • 76
    • 85007013147 scopus 로고    scopus 로고
    • Measures of glycemic variability in type 1 diabetes and the effect of real-time continuous glucose monitoring
    • El-Laboudi AH, Godsland IF, Johnston DG, Oliver NS. Measures of glycemic variability in type 1 diabetes and the effect of real-time continuous glucose monitoring. Diabetes Technol Ther 2016;18:806-812
    • (2016) Diabetes Technol Ther , vol.18 , pp. 806-812
    • El-Laboudi, A.H.1    Godsland, I.F.2    Johnston, D.G.3    Oliver, N.S.4
  • 77
    • 85016207511 scopus 로고    scopus 로고
    • Toward defining the threshold between low and high glucose variability in diabetes
    • Monnier L, Colette C, Wojtusciszyn A, et al. Toward defining the threshold between low and high glucose variability in diabetes. Diabetes Care 2017;40:832-838
    • (2017) Diabetes Care , vol.40 , pp. 832-838
    • Monnier, L.1    Colette, C.2    Wojtusciszyn, A.3
  • 78
    • 70349249912 scopus 로고    scopus 로고
    • Interpretation of continuous glucose monitoring data: Glycemic variability and quality of glycemic control
    • Rodbard D. Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther 2009;11(Suppl. 1):S55-S67
    • (2009) Diabetes Technol Ther , vol.11 , pp. S55-S67
    • Rodbard, D.1
  • 79
    • 85036667757 scopus 로고    scopus 로고
    • International Diabetes Center. Accessed 17 July
    • International Diabetes Center. AGP - Ambulatory Glucose Profile: AGP reports. Available from http://www.agpreport.org/agp/agpreports. Accessed 17 July 2017
    • (2017) AGP - Ambulatory Glucose Profile: AGP Reports
  • 80
    • 85036609642 scopus 로고    scopus 로고
    • Medtronic. Accessed 29 August
    • Medtronic. New CareLink iPro Pattern Snapshot. Available from https://professional. medtronicdiabetes.com/para/new-carelink-ipro-pattern-snapshot-report. Accessed 29 August 2017
    • (2017) New CareLink IPro Pattern Snapshot
  • 82
    • 84875132724 scopus 로고    scopus 로고
    • Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: The Ambulatory Glucose Profile (AGP)
    • Bergenstal RM, Ahmann AJ, Bailey T, et al. Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). Diabetes Technol Ther 2013;15:198-211
    • (2013) Diabetes Technol Ther , vol.15 , pp. 198-211
    • Bergenstal, R.M.1    Ahmann, A.J.2    Bailey, T.3
  • 83
    • 79952173244 scopus 로고    scopus 로고
    • Juvenile diabetes research foundation continuous glucose monitoring study group. Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring
    • Xing D, Kollman C, Beck RW, et al.; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring. Diabetes Technol Ther 2011;13:351-358
    • (2011) Diabetes Technol Ther , vol.13 , pp. 351-358
    • Xing, D.1    Kollman, C.2    Beck, R.W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.